Boya Gene was established in 2015 and currently has four platforms centered on gene editing technology, and is committed to promoting R&D projects for genetic diseases and tumors into the clinic. The four platforms include an in vitro cell gene editing therapy platform for hematopoietic stem cells and T cells, an in vivo gene editing therapy platform based on RNA single-base editing technology, and a high-throughput genome edi...
Boya Gene was established in 2015 and currently has four platforms centered on gene editing technology, and is committed to promoting R&D projects for genetic diseases and tumors into the clinic. The four platforms include an in vitro cell gene editing therapy platform for hematopoietic stem cells and T cells, an in vivo gene editing therapy platform based on RNA single-base editing technology, and a high-throughput genome editing screening platform dedicated to targeted drug development. At the same time, Boya Gene has established a clinical transformation application base that meets GMP standards in Nansha District, Guangzhou in 2018 .
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.